IL-6/STAT3 signaling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis
P. C. Arneson-Wissink, H. Mendez, K. Pelz, J. Dickie, A. Q. Bartlett, B. L. Worley, S. M. Krasnow, R. Eil, A. J. Grossberg
This study identifies IL-6/STAT3 signaling as a driver of early-stage pancreatic cancer cachexia by suppressing ketogenesis and lipid oxidation in the liver.
Journal of Cachexia, Sarcopenia and Muscle · Apr 17, 2024Peer-reviewedCancer Biology